vs
STANDARD BIOTOOLS INC.（LAB）与WEST BANCORPORATION INC（WTBA）财务数据对比。点击上方公司名可切换其他公司
WEST BANCORPORATION INC的季度营收约是STANDARD BIOTOOLS INC.的1.4倍（$26.9M vs $19.6M），WEST BANCORPORATION INC净利率更高（39.2% vs -177.4%，领先216.7%），WEST BANCORPORATION INC同比增速更快（16.6% vs -11.5%），WEST BANCORPORATION INC自由现金流更多（$12.4M vs $-23.1M），过去两年WEST BANCORPORATION INC的营收复合增速更高（17.3% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
West Bancorporation Inc.是总部位于美国中西部的区域性金融控股公司，主要服务爱荷华州、明尼苏达州两地市场，面向不同群体提供多元化个人及商业银行服务，包括存款账户、按揭贷款、企业信贷、财富管理等专业解决方案，覆盖个人客户、中小企业及本地机构客户。
LAB vs WTBA — 直观对比
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $26.9M |
| 净利润 | $-34.7M | $10.6M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 50.0% |
| 净利率 | -177.4% | 39.2% |
| 营收同比 | -11.5% | 16.6% |
| 净利润同比 | -28.8% | 34.8% |
| 每股收益（稀释后） | $-0.09 | $0.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | — | $26.9M | ||
| Q4 25 | — | $24.2M | ||
| Q3 25 | $19.6M | $25.0M | ||
| Q2 25 | $21.8M | $23.8M | ||
| Q1 25 | $40.8M | $23.1M | ||
| Q4 24 | — | $20.9M | ||
| Q3 24 | $22.1M | $20.3M | ||
| Q2 24 | $22.5M | $19.6M |
| Q1 26 | — | $10.6M | ||
| Q4 25 | — | $7.4M | ||
| Q3 25 | $-34.7M | $9.3M | ||
| Q2 25 | $-33.5M | $8.0M | ||
| Q1 25 | $-26.0M | $7.8M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | $-26.9M | $6.0M | ||
| Q2 24 | $-45.7M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — |
| Q1 26 | — | 50.0% | ||
| Q4 25 | — | 39.6% | ||
| Q3 25 | -168.5% | 45.8% | ||
| Q2 25 | -118.1% | 43.4% | ||
| Q1 25 | -80.8% | 43.4% | ||
| Q4 24 | — | 30.9% | ||
| Q3 24 | -120.9% | 36.6% | ||
| Q2 24 | -134.5% | 32.6% |
| Q1 26 | — | 39.2% | ||
| Q4 25 | — | 30.7% | ||
| Q3 25 | -177.4% | 37.3% | ||
| Q2 25 | -153.7% | 33.5% | ||
| Q1 25 | -63.8% | 34.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | -122.0% | 29.3% | ||
| Q2 24 | -203.3% | 26.5% |
| Q1 26 | — | $0.61 | ||
| Q4 25 | — | $0.44 | ||
| Q3 25 | $-0.09 | $0.55 | ||
| Q2 25 | $-0.09 | $0.47 | ||
| Q1 25 | $-0.07 | $0.46 | ||
| Q4 24 | — | $0.41 | ||
| Q3 24 | $-0.07 | $0.35 | ||
| Q2 24 | $-0.12 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $362.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $270.7M |
| 总资产 | $539.6M | $4.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | — | $362.0M | ||
| Q4 25 | — | $471.1M | ||
| Q3 25 | $129.4M | $232.9M | ||
| Q2 25 | $158.6M | $345.2M | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | $243.5M | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — |
| Q1 26 | — | $270.7M | ||
| Q4 25 | — | $266.0M | ||
| Q3 25 | $399.7M | $255.1M | ||
| Q2 25 | $424.5M | $240.9M | ||
| Q1 25 | $454.6M | $237.9M | ||
| Q4 24 | — | $227.9M | ||
| Q3 24 | $489.3M | $235.4M | ||
| Q2 24 | $510.3M | $223.9M |
| Q1 26 | — | $4.0B | ||
| Q4 25 | — | $4.1B | ||
| Q3 25 | $539.6M | $4.0B | ||
| Q2 25 | $557.0M | $4.1B | ||
| Q1 25 | $579.6M | $4.0B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | $681.5M | $4.0B | ||
| Q2 24 | $708.7M | $4.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $12.9M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $12.4M |
| 自由现金流率自由现金流/营收 | -118.1% | 46.0% |
| 资本支出强度资本支出/营收 | 4.5% | 1.8% |
| 现金转化率经营现金流/净利润 | — | 1.22× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $79.1M |
8季度趋势，按日历期对齐
| Q1 26 | — | $12.9M | ||
| Q4 25 | — | $46.5M | ||
| Q3 25 | $-22.2M | $11.4M | ||
| Q2 25 | $-20.7M | $13.5M | ||
| Q1 25 | $-30.3M | $9.7M | ||
| Q4 24 | — | $39.8M | ||
| Q3 24 | $-27.9M | $12.9M | ||
| Q2 24 | $-39.0M | $10.0M |
| Q1 26 | — | $12.4M | ||
| Q4 25 | — | $43.2M | ||
| Q3 25 | $-23.1M | $10.8M | ||
| Q2 25 | $-22.6M | $12.8M | ||
| Q1 25 | $-35.3M | $8.3M | ||
| Q4 24 | — | $13.7M | ||
| Q3 24 | $-30.1M | $7.0M | ||
| Q2 24 | $-41.0M | $2.7M |
| Q1 26 | — | 46.0% | ||
| Q4 25 | — | 178.3% | ||
| Q3 25 | -118.1% | 43.0% | ||
| Q2 25 | -103.6% | 53.6% | ||
| Q1 25 | -86.6% | 35.7% | ||
| Q4 24 | — | 65.6% | ||
| Q3 24 | -136.4% | 34.2% | ||
| Q2 24 | -182.2% | 14.0% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | — | 13.7% | ||
| Q3 25 | 4.5% | 2.6% | ||
| Q2 25 | 8.7% | 3.2% | ||
| Q1 25 | 12.4% | 6.5% | ||
| Q4 24 | — | 125.3% | ||
| Q3 24 | 10.2% | 29.4% | ||
| Q2 24 | 8.6% | 37.1% |
| Q1 26 | — | 1.22× | ||
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.70× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 5.61× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | 1.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
WTBA
暂无分部数据
